 | • レポートコード：GIR-107A12281 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、濾胞性菌状息肉腫治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。濾胞性菌状息肉腫治療の種類別市場規模（小分子、生物製剤）、用途別市場規模（病院、専門クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・濾胞性菌状息肉腫治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Takeda Pharmaceutical Company、Merck、Seattle Genetics、Kyowa Kirin、Eisai、Helsinn Healthcare、Horizon Therapeutics、Celegene Corporation、Azurity Pharmaceuticals、Elorac、Soligenix、Actelion Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：小分子、生物製剤 ・用途別分析2016年-2026年：病院、専門クリニック、その他 ・濾胞性菌状息肉腫治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・濾胞性菌状息肉腫治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・濾胞性菌状息肉腫治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・濾胞性菌状息肉腫治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・濾胞性菌状息肉腫治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Folliculotropic Mycosis Fungoides Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Folliculotropic Mycosis Fungoides Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Folliculotropic Mycosis Fungoides Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Folliculotropic Mycosis Fungoides Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Small Molecule
Biologics
Market segment by Application, can be divided into
Hospital
Specialty Clinic
Others
Market segment by players, this report covers
Takeda Pharmaceutical Company
Merck
Seattle Genetics
Kyowa Kirin
Eisai
Helsinn Healthcare
Horizon Therapeutics
Celegene Corporation
Azurity Pharmaceuticals
Elorac
Soligenix
Actelion Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Folliculotropic Mycosis Fungoides Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Folliculotropic Mycosis Fungoides Treatment, with revenue, gross margin and global market share of Folliculotropic Mycosis Fungoides Treatment from 2019 to 2021.
Chapter 3, the Folliculotropic Mycosis Fungoides Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Folliculotropic Mycosis Fungoides Treatment market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Folliculotropic Mycosis Fungoides Treatment research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Folliculotropic Mycosis Fungoides Treatment
1.2 Classification of Folliculotropic Mycosis Fungoides Treatment by Type
1.2.1 Overview: Global Folliculotropic Mycosis Fungoides Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Type in 2020
1.2.3 Small Molecule
1.2.4 Biologics
1.3 Global Folliculotropic Mycosis Fungoides Treatment Market by Application
1.3.1 Overview: Global Folliculotropic Mycosis Fungoides Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Global Folliculotropic Mycosis Fungoides Treatment Market Size & Forecast
1.5 Global Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast by Region
1.5.1 Global Folliculotropic Mycosis Fungoides Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Folliculotropic Mycosis Fungoides Treatment Market Size by Region, (2016-2021)
1.5.3 North America Folliculotropic Mycosis Fungoides Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Folliculotropic Mycosis Fungoides Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Folliculotropic Mycosis Fungoides Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Folliculotropic Mycosis Fungoides Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Folliculotropic Mycosis Fungoides Treatment Market Drivers
1.6.2 Folliculotropic Mycosis Fungoides Treatment Market Restraints
1.6.3 Folliculotropic Mycosis Fungoides Treatment Trends Analysis
2 Company Profiles
2.1 Takeda Pharmaceutical Company
2.1.1 Takeda Pharmaceutical Company Details
2.1.2 Takeda Pharmaceutical Company Major Business
2.1.3 Takeda Pharmaceutical Company Folliculotropic Mycosis Fungoides Treatment Product and Solutions
2.1.4 Takeda Pharmaceutical Company Folliculotropic Mycosis Fungoides Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Takeda Pharmaceutical Company Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Folliculotropic Mycosis Fungoides Treatment Product and Solutions
2.2.4 Merck Folliculotropic Mycosis Fungoides Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck Recent Developments and Future Plans
2.3 Seattle Genetics
2.3.1 Seattle Genetics Details
2.3.2 Seattle Genetics Major Business
2.3.3 Seattle Genetics Folliculotropic Mycosis Fungoides Treatment Product and Solutions
2.3.4 Seattle Genetics Folliculotropic Mycosis Fungoides Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Seattle Genetics Recent Developments and Future Plans
2.4 Kyowa Kirin
2.4.1 Kyowa Kirin Details
2.4.2 Kyowa Kirin Major Business
2.4.3 Kyowa Kirin Folliculotropic Mycosis Fungoides Treatment Product and Solutions
2.4.4 Kyowa Kirin Folliculotropic Mycosis Fungoides Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Kyowa Kirin Recent Developments and Future Plans
2.5 Eisai
2.5.1 Eisai Details
2.5.2 Eisai Major Business
2.5.3 Eisai Folliculotropic Mycosis Fungoides Treatment Product and Solutions
2.5.4 Eisai Folliculotropic Mycosis Fungoides Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Eisai Recent Developments and Future Plans
2.6 Helsinn Healthcare
2.6.1 Helsinn Healthcare Details
2.6.2 Helsinn Healthcare Major Business
2.6.3 Helsinn Healthcare Folliculotropic Mycosis Fungoides Treatment Product and Solutions
2.6.4 Helsinn Healthcare Folliculotropic Mycosis Fungoides Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Helsinn Healthcare Recent Developments and Future Plans
2.7 Horizon Therapeutics
2.7.1 Horizon Therapeutics Details
2.7.2 Horizon Therapeutics Major Business
2.7.3 Horizon Therapeutics Folliculotropic Mycosis Fungoides Treatment Product and Solutions
2.7.4 Horizon Therapeutics Folliculotropic Mycosis Fungoides Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Horizon Therapeutics Recent Developments and Future Plans
2.8 Celegene Corporation
2.8.1 Celegene Corporation Details
2.8.2 Celegene Corporation Major Business
2.8.3 Celegene Corporation Folliculotropic Mycosis Fungoides Treatment Product and Solutions
2.8.4 Celegene Corporation Folliculotropic Mycosis Fungoides Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Celegene Corporation Recent Developments and Future Plans
2.9 Azurity Pharmaceuticals
2.9.1 Azurity Pharmaceuticals Details
2.9.2 Azurity Pharmaceuticals Major Business
2.9.3 Azurity Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Product and Solutions
2.9.4 Azurity Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Azurity Pharmaceuticals Recent Developments and Future Plans
2.10 Elorac
2.10.1 Elorac Details
2.10.2 Elorac Major Business
2.10.3 Elorac Folliculotropic Mycosis Fungoides Treatment Product and Solutions
2.10.4 Elorac Folliculotropic Mycosis Fungoides Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Elorac Recent Developments and Future Plans
2.11 Soligenix
2.11.1 Soligenix Details
2.11.2 Soligenix Major Business
2.11.3 Soligenix Folliculotropic Mycosis Fungoides Treatment Product and Solutions
2.11.4 Soligenix Folliculotropic Mycosis Fungoides Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Soligenix Recent Developments and Future Plans
2.12 Actelion Pharmaceuticals
2.12.1 Actelion Pharmaceuticals Details
2.12.2 Actelion Pharmaceuticals Major Business
2.12.3 Actelion Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Product and Solutions
2.12.4 Actelion Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Actelion Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Folliculotropic Mycosis Fungoides Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Folliculotropic Mycosis Fungoides Treatment Players Market Share
3.2.2 Top 10 Folliculotropic Mycosis Fungoides Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Folliculotropic Mycosis Fungoides Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Folliculotropic Mycosis Fungoides Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Folliculotropic Mycosis Fungoides Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Application (2016-2021)
5.2 Folliculotropic Mycosis Fungoides Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2016-2026)
6.2 North America Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2016-2026)
6.3 North America Folliculotropic Mycosis Fungoides Treatment Market Size by Country
6.3.1 North America Folliculotropic Mycosis Fungoides Treatment Revenue by Country (2016-2026)
6.3.2 United States Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2016-2026)
7.2 Europe Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2016-2026)
7.3 Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Country
7.3.1 Europe Folliculotropic Mycosis Fungoides Treatment Revenue by Country (2016-2026)
7.3.2 Germany Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
7.3.3 France Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Region
8.3.1 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue by Region (2016-2026)
8.3.2 China Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
8.3.5 India Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2016-2026)
9.2 South America Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2016-2026)
9.3 South America Folliculotropic Mycosis Fungoides Treatment Market Size by Country
9.3.1 South America Folliculotropic Mycosis Fungoides Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Country
10.3.1 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Folliculotropic Mycosis Fungoides Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Folliculotropic Mycosis Fungoides Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Folliculotropic Mycosis Fungoides Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Folliculotropic Mycosis Fungoides Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Region (2021-2026)
Table 6. Takeda Pharmaceutical Company Corporate Information, Head Office, and Major Competitors
Table 7. Takeda Pharmaceutical Company Major Business
Table 8. Takeda Pharmaceutical Company Folliculotropic Mycosis Fungoides Treatment Product and Solutions
Table 9. Takeda Pharmaceutical Company Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Folliculotropic Mycosis Fungoides Treatment Product and Solutions
Table 13. Merck Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Seattle Genetics Corporate Information, Head Office, and Major Competitors
Table 15. Seattle Genetics Major Business
Table 16. Seattle Genetics Folliculotropic Mycosis Fungoides Treatment Product and Solutions
Table 17. Seattle Genetics Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Kyowa Kirin Corporate Information, Head Office, and Major Competitors
Table 19. Kyowa Kirin Major Business
Table 20. Kyowa Kirin Folliculotropic Mycosis Fungoides Treatment Product and Solutions
Table 21. Kyowa Kirin Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Eisai Corporate Information, Head Office, and Major Competitors
Table 23. Eisai Major Business
Table 24. Eisai Folliculotropic Mycosis Fungoides Treatment Product and Solutions
Table 25. Eisai Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Helsinn Healthcare Corporate Information, Head Office, and Major Competitors
Table 27. Helsinn Healthcare Major Business
Table 28. Helsinn Healthcare Folliculotropic Mycosis Fungoides Treatment Product and Solutions
Table 29. Helsinn Healthcare Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Horizon Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. Horizon Therapeutics Major Business
Table 32. Horizon Therapeutics Folliculotropic Mycosis Fungoides Treatment Product and Solutions
Table 33. Horizon Therapeutics Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Celegene Corporation Corporate Information, Head Office, and Major Competitors
Table 35. Celegene Corporation Major Business
Table 36. Celegene Corporation Folliculotropic Mycosis Fungoides Treatment Product and Solutions
Table 37. Celegene Corporation Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Azurity Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Azurity Pharmaceuticals Major Business
Table 40. Azurity Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Product and Solutions
Table 41. Azurity Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Elorac Corporate Information, Head Office, and Major Competitors
Table 43. Elorac Major Business
Table 44. Elorac Folliculotropic Mycosis Fungoides Treatment Product and Solutions
Table 45. Elorac Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Soligenix Corporate Information, Head Office, and Major Competitors
Table 47. Soligenix Major Business
Table 48. Soligenix Folliculotropic Mycosis Fungoides Treatment Product and Solutions
Table 49. Soligenix Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Actelion Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 51. Actelion Pharmaceuticals Major Business
Table 52. Actelion Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Product and Solutions
Table 53. Actelion Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million) by Players (2019-2021)
Table 55. Global Folliculotropic Mycosis Fungoides Treatment Revenue Share by Players (2019-2021)
Table 56. Breakdown of Folliculotropic Mycosis Fungoides Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Folliculotropic Mycosis Fungoides Treatment Players Head Office, Products and Services Provided
Table 58. Folliculotropic Mycosis Fungoides Treatment Mergers & Acquisitions in the Past Five Years
Table 59. Folliculotropic Mycosis Fungoides Treatment New Entrants and Expansion Plans
Table 60. Global Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million) by Type (2016-2021)
Table 61. Global Folliculotropic Mycosis Fungoides Treatment Revenue Share by Type (2016-2021)
Table 62. Global Folliculotropic Mycosis Fungoides Treatment Revenue Forecast by Type (2021-2026)
Table 63. Global Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2016-2021)
Table 64. Global Folliculotropic Mycosis Fungoides Treatment Revenue Forecast by Application (2021-2026)
Table 65. North America Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Folliculotropic Mycosis Fungoides Treatment Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Folliculotropic Mycosis Fungoides Treatment Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Folliculotropic Mycosis Fungoides Treatment Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Folliculotropic Mycosis Fungoides Treatment Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Folliculotropic Mycosis Fungoides Treatment Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Folliculotropic Mycosis Fungoides Treatment Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Folliculotropic Mycosis Fungoides Treatment Picture
Figure 2. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Type in 2020
Figure 3. Small Molecule
Figure 4. Biologics
Figure 5. Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Specialty Clinic Picture
Figure 8. Others Picture
Figure 9. Global Folliculotropic Mycosis Fungoides Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Folliculotropic Mycosis Fungoides Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Region (2016-2026)
Figure 12. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Region in 2020
Figure 13. North America Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Folliculotropic Mycosis Fungoides Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Folliculotropic Mycosis Fungoides Treatment Market Drivers
Figure 19. Folliculotropic Mycosis Fungoides Treatment Market Restraints
Figure 20. Folliculotropic Mycosis Fungoides Treatment Market Trends
Figure 21. Takeda Pharmaceutical Company Recent Developments and Future Plans
Figure 22. Merck Recent Developments and Future Plans
Figure 23. Seattle Genetics Recent Developments and Future Plans
Figure 24. Kyowa Kirin Recent Developments and Future Plans
Figure 25. Eisai Recent Developments and Future Plans
Figure 26. Helsinn Healthcare Recent Developments and Future Plans
Figure 27. Horizon Therapeutics Recent Developments and Future Plans
Figure 28. Celegene Corporation Recent Developments and Future Plans
Figure 29. Azurity Pharmaceuticals Recent Developments and Future Plans
Figure 30. Elorac Recent Developments and Future Plans
Figure 31. Soligenix Recent Developments and Future Plans
Figure 32. Actelion Pharmaceuticals Recent Developments and Future Plans
Figure 33. Global Folliculotropic Mycosis Fungoides Treatment Revenue Share by Players in 2020
Figure 34. Folliculotropic Mycosis Fungoides Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Folliculotropic Mycosis Fungoides Treatment Revenue Market Share in 2020
Figure 36. Global Top 10 Players Folliculotropic Mycosis Fungoides Treatment Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Folliculotropic Mycosis Fungoides Treatment Revenue Share by Type in 2020
Figure 39. Global Folliculotropic Mycosis Fungoides Treatment Market Share Forecast by Type (2021-2026)
Figure 40. Global Folliculotropic Mycosis Fungoides Treatment Revenue Share by Application in 2020
Figure 41. Global Folliculotropic Mycosis Fungoides Treatment Market Share Forecast by Application (2021-2026)
Figure 42. North America Folliculotropic Mycosis Fungoides Treatment Sales Market Share by Type (2016-2026)
Figure 43. North America Folliculotropic Mycosis Fungoides Treatment Sales Market Share by Application (2016-2026)
Figure 44. North America Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Country (2016-2026)
Figure 45. United States Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Folliculotropic Mycosis Fungoides Treatment Sales Market Share by Type (2016-2026)
Figure 49. Europe Folliculotropic Mycosis Fungoides Treatment Sales Market Share by Application (2016-2026)
Figure 50. Europe Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Country (2016-2026)
Figure 51. Germany Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Region (2016-2026)
Figure 59. China Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Folliculotropic Mycosis Fungoides Treatment Sales Market Share by Type (2016-2026)
Figure 66. South America Folliculotropic Mycosis Fungoides Treatment Sales Market Share by Application (2016-2026)
Figure 67. South America Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Folliculotropic Mycosis Fungoides Treatment Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Folliculotropic Mycosis Fungoides Treatment Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Folliculotropic Mycosis Fungoides Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の軟骨無形成症治療市場 2021：企業別、地域別、種類・用途別 The Achondroplasia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…- 世界の髄膜炎菌感染症治療市場 2021：企業別、地域別、種類・用途別 The Meningococcal Infections Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界のグルテン不耐性治療市場 2021：企業別、地域別、種類・用途別 The Gluten Intolerance Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の総胆管結石症治療市場 2021：企業別、地域別、種類・用途別 The Choledocholithiasis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の黄熱病治療市場 2021：企業別、地域別、種類・用途別 The Yellow Fever Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…